Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy

Saved in:
Bibliographic Details
Published inClinical journal of the American Society of Nephrology Vol. 18; no. 6; pp. 785 - 787
Main Authors Teisseyre, Maxime, Brglez, Vesna, Cremoni, Marion, Fernandez, Céline, Graça, Daisy, Boyer-Suavet, Sonia, Benzaken, Sylvia, Esnault, Vincent L.M., Seitz-Polski, Barbara
Format Journal Article
LanguageEnglish
Published United States American Society of Nephrology 01.06.2023
Subjects
Glomerulonephritis, Membranous - drug therapy
Humans
Immunologic Factors
Immunosuppressive Agents
Receptors, Phospholipase A2
Risk Factors
Rituximab - therapeutic use
immunomonitoring
antidrug antibodies, risk factors
PLA2R1
membranous nephropathy
immunology
nephrotic syndrome
rituximab
Online AccessGet full text

Cover

More Information
Bibliography:Correspondence: Dr. Barbara Seitz-Polski, Laboratoire d'Immunologie, Centre Hospitalier Universitaire de Nice, Hôpital de l'Archet, 151 Route de Saint-Antoine 06200 Nice, France. Email: seitz-polski.b@chu-nice.fr
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1555-9041
1555-905X
1555-905X
DOI:10.2215/CJN.0000000000000152